Inventor · disambiguated record
Alan R. Saltiel
Also filed as: SALTIEL ALAN R · SALTIEL ALAN ROBERT · SALTIEL Alan
23 granted patents·6 pending applications·1,020 citations·filing 1986–2025
97Inventor score
Files withWARNER LAMBERT CO15UNIV MICHIGAN4UNIV MICHIGAN REGENTS3UNIV ROCKEFELLER2SALK INST FOR BIOLOGICAL STUDI1
Top patents by PatentIndex Score
29 records- 0198US6310060B12-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as MEK inhibitorsWARNER LAMBERT CO·Filed 1998·Granted Oct 30, 2001·146 cites·37 claims
- 0297US7169816B24-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitorsWARNER LAMBERT CO·Filed 2005·Granted Jan 30, 2007·30 cites·16 claims
- 0397US6821963B24-Bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitorsWARNER LAMBERT CO·Filed 2002·Granted Nov 23, 2004·52 cites·21 claims
- 0497US5756544ACarboxyalkylethers, formulations, and treatment of vascular diseasesWARNER LAMBERT CO·Filed 1997·Granted May 26, 1998·131 cites·6 claims
- 0596US5525625A2-(2-Amino-3-methoxyphenyl)-4-oxo-4H-[1]benzopyran for treating proliferative disordersWARNER LAMBERT CO·Filed 1995·Granted Jun 11, 1996·200 cites·8 claims
- 0694US5648387ACarboxyalkylethers, formulations, and treatment of vascular diseasesWARNER LAMBERT CO·Filed 1995·Granted Jul 15, 1997·133 cites·21 claims
- 0793US7019033B22-(4-bromo or 4-iodo phenylamino) benzoic acid derivativesWARNER LAMBERT CO·Filed 2002·Granted Mar 28, 2006·26 cites·11 claims
- 0892US5783600ACarboxyalkylethers, formulations, and treatment of vascular diseasesWARNER LAMBERT CO·Filed 1997·Granted Jul 21, 1998·92 cites·8 claims
- 0990US5750569ACarboxyalkylethers, formulations, and treatment of vascular diseasesWARNER LAMBERT CO·Filed 1997·Granted May 12, 1998·73 cites·8 claims
- 1087US8946424B2Deuterated amlexanoxUNIV MICHIGAN·Filed 2014·Granted Feb 3, 2015·7 cites·9 claims
- 1187US6492363B22-(4-bromo or 4-iodo phenylamino) benzoic acid derivativesWARNER LAMBERT CO·Filed 2001·Granted Dec 10, 2002·14 cites·35 claims
- 1272US6696440B1Treatment of asthma with MEK inhibitorsWARNER LAMBERT CO·Filed 1999·Granted Feb 24, 2004·34 cites·13 claims
- 1371US4906468AInsulin activity messengers, their antibodies, and thereofUNIV ROCKEFELLER·Filed 1986·Granted Mar 6, 1990·12 cites·3 claims
- 1464US10590142B2Deuterated amlexanoxUNIV MICHIGAN REGENTS·Filed 2018·Granted Mar 17, 2020·0 cites·11 claims
- 1564US9365581B2Deuterated amlexanoxUNIV MICHIGAN·Filed 2014·Granted Jun 14, 2016·0 cites·9 claims
- 1661US4839466AInsulin activity messengersUNIV ROCKEFELLER·Filed 1987·Granted Jun 13, 1989·23 cites·5 claims
- 1759US9944652B2Deuterated amlexanoxUNIV MICHIGAN REGENTS·Filed 2016·Granted Apr 17, 2018·0 cites·10 claims
- 1858US6251943B1Method of treating or preventing septic shock by administering a MEK inhibitorWARNER LAMBERT CO·Filed 1997·Granted Jun 26, 2001·18 cites·9 claims
- 1954US2005049429A14-Bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitorsFiled 2004·Application pending·0 cites
- 2051US2004141924A1Treatment of asthma with MEK inhibitorsFiled 2004·Application pending·0 cites
- 2149US2025319162A1Methods and materials for treating obesityUNIV CALIFORNIA·Filed 2025·Application pending·0 cites
- 2248US5922697ACompounds, compositions and methods for inhibiting the binding of proteins containing an SH2 domain to cognate phosphorylated proteinsWARNER LAMBERT CO·Filed 1996·Granted Jul 13, 1999·12 cites·17 claims
- 2345US6252057B1Protein targeting to glycogenWARNER LAMBERT CO·Filed 1997·Granted Jun 26, 2001·14 cites·14 claims
- 2443US2009304714A1IKKi Inhibitor Therapies and Screening Methods, and Related IKKi DiagnosticsUNIV MICHIGAN·Filed 2009·Application pending·0 cites
- 2541US2015224089A1COMBINATIONS OF IKKi/TBK1 INHIBITORS WITH BETA ADRENERGIC AGONISTS OR SYMPATHETIC NERVOUS SYSTEM ACTIVATORSUNIV MICHIGAN·Filed 2015·Application pending·0 cites
- 2639US2015258052A1Methods of using fexaramine and agents that increase sympathetic nervous system activity to promote browning of white adipose tissueSALK INST FOR BIOLOGICAL STUDI·Filed 2015·Application pending·0 cites
- 2737US10214536B2Amlexanox analogsUNIV MICHIGAN REGENTS·Filed 2017·Granted Feb 26, 2019·0 cites·4 claims
- 2832US5721266ASubstituted imidazolinyl-imidazolines as antagonists of SH-2 binding and therapeutic uses thereofWARNER LAMBERT CO·Filed 1994·Granted Feb 24, 1998·3 cites·11 claims
- 2930US10245255B2Compositions and methods for the treatment of obesity and related disordersSALTIEL ALAN R·Filed 2012·Granted Apr 2, 2019·0 cites·13 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →